Completed

Ambulatory Pulse Wave Velocity and Central Augmentation Index Reproducibility in Type 2 Diabetes

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to observe the consistency of pulse wave analysis in individuals with Type 2 Diabetes by measuring the fraction of missed measurements during day time and night time blood pressure analysis.

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Endocrine System Diseases+3

+ Metabolic Diseases

+ Nutritional and Metabolic Diseases

From 30 to 75 Years
+2 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Observational
Study Start: September 2012
See protocol details

Summary

Principal SponsorUniversity of Aarhus
Last updated: December 11, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2012

Actual date on which the first participant was enrolled.

Arteriograph24 is a new monitor for measuring ambulatory blood pressure and additional performing brachial cuff based on analysis of a suprasystolic pulse wave. The study aim to test the feasibility of ambulatory pulse wave analysis every twenty minute (the fraction of missed measurements)and the reprodicility of pulse wave velocity and central augmentation index in type 2 diabetic patients. In addition we will explore the relation between diurnal variation of brachial blood pressure, central blood pressure and pulse wave velocity. 20 type 2 diabetic patients will have 24h ambulatory blood pressure performed twice with an interval of one week.

NCT01812811
Principal SponsorUniversity of Aarhus
Last updated: December 11, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

22 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 30 to 75 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Endocrine System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesGlucose Metabolism DisordersDiabetes MellitusDiabetes Mellitus, Type 2

Criteria

1 inclusion criteria required to participate
Type 2 diabetes
1 exclusion criteria prevent from participating
Atrial fibrillation

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Medical department, Diagnostic Center, Regional Hospital Silkeborg

Silkeborg, DenmarkOpen Medical department, Diagnostic Center, Regional Hospital Silkeborg in Google Maps
CompletedOne Study Center